Longevity science is having a cultural moment. Molecules like NMN and NAD, central to research on cellular aging, have leapt from biology papers into the wellness mainstream, driving a booming market in supplements and IV drips promising to slow the clock. It was only a matter of time before they crossed into topical skincare, and KAHI's Eye Balm CV is one of the products riding that wave, listing nicotinamide mononucleotide, nicotinamide adenine dinucleotide and ATP among its ingredients, a cellular-energy bouquet borrowed straight from the longevity conversation. The honest place to start a review of this balm is by separating that buzzy story from what actually works in it, because the gap is wide.
Here is the reality on the longevity actives: topical evidence for NMN, NAD and ATP is minimal. The excitement around these molecules comes overwhelmingly from oral and intravenous use in aging research, where the science is itself still maturing and contested, and almost none of it translates to a wax balm smeared under your eye. Whether these large, delicate molecules even penetrate the skin meaningfully, let alone exert a cellular-energy benefit, is unestablished. In this eye balm, they are an on-trend marketing flourish, a way to attach a fashionable scientific narrative to a stick, not a proven treatment. Buy the balm for what it genuinely does, not for the promise of cellular rejuvenation, which it cannot deliver topically.
What it genuinely does is reasonably good, and here the formula is actually more thoughtfully built than the gimmicky actives suggest. There is escin, a horse-chestnut compound with a long traditional and some experimental basis for de-puffing and supporting circulation, a genuinely sensible inclusion for the under-eye, where puffiness is a common concern. There is adenosine, the most evidence-backed fine-line active in the formula, well suited to the eye contour. And the base is a rich, nourishing blend of sunflower, almond, apple seed and macadamia oils with cupuacu butter, plus, notably, soothing bisabolol, which makes this version feel a touch gentler and more cushioning than the salmon-based original eye balm. The caviar ferment, like the salmon complex it replaces, is a luxury-positioned hero of limited topical evidence that mostly conditions and plumps the surface. So beneath the longevity hype sits a competent, even slightly sophisticated, nourishing eye balm with two legitimately targeted eye actives.
The problem, and it is the same one that runs through KAHI's entire balm range, is fragrance, and it is at its most concerning here because this is an eye product. The balm contains added parfum plus seven declared allergens, benzyl benzoate, hexyl cinnamal, benzyl salicylate, hydroxycitronellal, citronellol, alpha-isomethyl ionone and linalool, applied directly to the most delicate, reactive skin on the face. The bisabolol helps, and this version is marginally less aggressive than some others in the line, but seven fragrance allergens at the eye contour directly contradicts the fundamental rule that eye products should be fragrance-free, and it makes this balm a real risk for sensitive, rosacea-prone or fragrance-allergic skin, the very people who might be drawn to an anti-aging eye treatment. For robust, fragrance-tolerant eyes it may never cause trouble; for reactive eyes it is a needless gamble.
The other caveats are familiar. As a rich balm it is for dry to normal skin and the under-eye specifically, not oily faces, and it is not fungal-acne safe. It is also not vegan, despite the CV line's clean-leaning positioning, because caviar extract is animal-derived. And expectations on dark circles should stay modest, structural and pigmentary darkness responds little to any topical, while hydration, the look of fine lines and a possible mild de-puffing are what it realistically offers.
Value is the weakest point. At a premium price, the highest of the KAHI balms reviewed here, you are paying for the caviar story, the longevity buzzwords and the loaded actives list, much of which is marketing. The genuinely useful parts, escin, adenosine, a nourishing soothing base, do not require a luxury price, and the fragrance undermines its suitability for the delicate area it targets. The refillable format helps the long-term economics somewhat.
Who should buy it? Dry and normal skin with robust, fragrance-tolerant eyes that is drawn to the premium caviar-and-longevity concept, wants a convenient, rich, de-puffing-leaning under-eye balm, and accepts both the fragrance and the price. Who should skip it? Anyone with sensitive eyes or reactive, rosacea-prone skin, for whom seven fragrance allergens at the eye are an avoidable risk, oily skin, those seeking a vegan product, budget-conscious shoppers, and anyone buying it for the NMN and NAD, which are longevity theater rather than topical substance. There is a decent eye balm buried under the buzzwords here; you just have to pay a premium and tolerate the fragrance to reach it. If you have followed this brand through its proliferating sticks, a clear strategic logic emerges: each new release bolts a fresher, buzzier hero onto the same proven balm chassis, salmon, then caviar, now longevity molecules, while the actual workhorses, oils, shea or cupuacu, adenosine, and a wax base, stay essentially constant. The Eye Balm CV is the furthest down that road, the most expensive and the most heavily marketed, and yet not meaningfully more effective than far cheaper eye treatments. That is not a scandal so much as a pattern worth recognizing, so you can buy the version that matches your fragrance tolerance and budget rather than the version with the trendiest molecule on the box.
